**Author details**

Michael S. Firstenberg\* and Jennifer M. Hanna Cardiothoracic and Thoracic Surgery, The Medical Center of Aurora, Aurora, CO, United States

\*Address all correspondence to: msfirst@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**9**

*Introductory Chapter: ECMO – Rapidly Evolving Technology, Expanding Indications…*

oxygenation-advances-in-therapy/ ecmo-biocompatibility-surfacecoatings-anticoagulation-andcoagulation-monitoring

[6] Australia and New Zealand

Davies A, Jones D, Bailey M,

Oct 12

Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators,

Beca J, Bellomo R, et al. Extracorporeal membrane oxygenation for 2009 influenza a(H1N1) acute respiratory distress syndrome. Journal of the American Medical Association. 2009;**302**(17):1888-1895. Epub 2009

[7] Firstenberg MS, Swaminath D. Left ventricular failure—Extra-corporeal membrane oxygenation: An update. World Society of Cardiothoracic Surgeons Journal. 2016;**1**(1):12-14

[8] Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive

extracorporeal membrane oxygenation

[9] Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al., CESAR Trial Collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory

adult patients treated with

for refractory postcardiotomy cardiogenic shock. The Journal of Thoracic and Cardiovascular Surgery.

2010;**139**(2):302-311, 311.e1

failure (CESAR): A multicentre randomised controlled trial. Lancet.

[10] Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. New England Journal of Medicine. 2018;**378**(21):1965-1975

2009;**374**(9698):1351-1363

*DOI: http://dx.doi.org/10.5772/intechopen.89475*

[1] Firstenberg MS. Introductory chapter: Evolution of ECMO from salvage to mainstream supportive and resuscitative therapy, extracorporeal membrane oxygenation. IntechOpen; 2016. DOI: 10.5772/64345. Available from: https://www.intechopen.com/ books/extracorporeal-membraneoxygenation-advances-in-therapy/ introductory-chapter-evolution-ofecmo-from-salvage-to-mainstreamsupportive-and-resuscitative-thera

[2] Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. Journal of the American Medical Association. 1979;**242**(20):2193-2196

[3] Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB. Extracorporeal

life support: The University of Michigan experience. Journal of the American Medical Association.

2000;**283**(7):904-908

oxygenation-support

[4] Bowling SM, Gomes J,

Firstenberg MS. Neurologic issues in patients receiving extracorporeal membrane oxygenation support, extracorporeal membrane oxygenation. Advances in Therapy, IntechOpen. 2016. DOI: 10.5772/64269. Available from: https://www.intechopen.com/ books/extracorporeal-membraneoxygenation-advances-in-therapy/ neurologic-issues-in-patientsreceiving-extracorporeal-membrane-

[5] Maul TM, Patricia Massicotte M, Wearden PD. ECMO biocompatibility: Surface coatings, anticoagulation, and coagulation monitoring,

extracorporeal membrane oxygenation. Advances in Therapy, IntechOpen. 2016. DOI: 10.5772/63888. Available from: https://www.intechopen.com/ books/extracorporeal-membrane-

**References**

*Introductory Chapter: ECMO – Rapidly Evolving Technology, Expanding Indications… DOI: http://dx.doi.org/10.5772/intechopen.89475*
